Indoco Remedies is hiring for production, QC & Microbiology Departments

About company:

Indoco is a fully integrated, research-oriented pharmaceutical company with a strong global presence . The Company’s turnover is US$ 180 million with a human capital of 6000 employees, including over 300 skilled scientists and Field. Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets. It generates more than 106 million prescriptions annually from over 2,43,000 doctors belonging to various specialties. The Company’s R&D team develops non-infringing processes for APIs, formulations and various dosage forms like Immediate Release Tablets, Capsules, Multi-Unit Pellet Systems (MUPS), PDDS, ER Tablets and nano suspensions, as well as a range of injectable solutions, suspensions and depot based long-acting injectables. Indoco has 11 domestic marketing divisions with a strong brand portfolio in various therapeutic segments, including Stomatologicals, Gastro-Intestinal, Respiratory, Anti-Infectives, Vitamins/Minerals/Nutrients, Cold & Cough, Ophthalmics, Antifungal, Antidiabetic & Cardiovascular, Urology, and several others. Top Indoco brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Cital UTI, Sensoform, Sensodent-KF, Aloja, Glychek, Kidodent, Tuspel Plus, Subitral, Rexidin, Dropizin, Tuspel LS, MCBM 69, Methycal, Cloben-G, Noxa, Homide, Cal-Aid, Ninaf, Otorex, Macuchek, Mofloren, Irivisc, PGVISC, Nepachek. Indoco exports a variety of products to regulated and emerging markets, including the USA and EU. The Company has tie-ups with large generic companies and works in close coordination with its customers to leverage core competencies. Indoco’s branded formulations are promoted and distributed across India and in Emerging Markets of South East Asia, Africa, Latin America and CIS. IAS division is USFDA approved and based at Navi Mumbai. It serves customers for their analytical research needs, utilizing state-of-utilizing state-of-the-art instruments and infrastructure.

Vacancy Details:

Job Description:

We are looking out for experienced and skilled professionals for our Sterile Formulations manufacturing facility in Goa across multiple roles.

A leading pharma Company with a strong global presence and international regulatory approvals including USFDA and UKMHRA

WALK-IN-INTERVIEWS Sterile Formulations Manufacturing facility in Goa

WE ARE HIRING

EXPERIENCE IN INJECTABLE & OPHTHALMIC PRODUCTS

1.DEPARTMENT: PRODUCTION

DESIGNATION: ASSOCIATE (OPERATOR)/OFFICER/EXECUTIVE (SHIFT INCHARGE) / MANAGER

Experience: 2 to 15 years

Qualification: Diploma / D.Pharma / BSC/B.Pharma/ M.Pharma

Job Profile: Experience in injectable, ophthalmic products (Mfg./ Filling/Washing/QMS/ Autoclave & Isolator) will be considered.

2.DEPARTMENT: QUALITY CONTROL

DESIGNATION: OFFICER/EXECUTIVE

Experience: 3 to 6 years

Qualification: BSC/MSC

Job Profile: Knowledge of handling HPLC, UV, Karl Fischer, Autotitrator, GC and dissolution in sterile and non- sterile.

3.DEPARTMENT: MICROBIOLOGY

DESIGNATION: OFFICER / EXECUTIVE / MANAGER

Experience: 5 to 15 years

Qualification: BSC/MSC (Microbiology / Biotechnology)

Job Profile: Experience in environment monitoring, QMS, routine & non routine analysis, PET, sterility, BET & water testing.

Note: Preference will be given to Goan candidates, subject to their qualifications and alignment with role requirements

Candidates must be willing to work in shifts.

Documents required: Copy of Aadhar Card, PAN Card and recent increment letter.

How to Apply?

Walk-in details:

DATE & TIME: JULY 20, 2025 & (SUNDAY) 10:00 AM TO 4:00 PM

Venue: THE PRESIDENT HOTEL,
194/1A, PB Road, Lake Srinagar Cross,
Opp. Unkal, Munneshwar Nagar, Hubli, Karnataka – 580031

Email: hrd2@indoco.com/career@indoco.com

Contact No.: 08326624209/7391054322

Notification of vacancies application receipt acknowledgment RQ250033080
Only experienced candidates can attend the interview



Leave a Reply

Your email address will not be published. Required fields are marked *